Literature DB >> 16823586

Sturge-Weber syndrome.

C Di Rocco1, G Tamburrini.   

Abstract

INTRODUCTION: Sturge-Weber syndrome (SWS) is a rare neurocutaneous syndrome the main clinical features of which are facial, mostly unilateral nevi, leptomeningeal angiomatosis, and congenital glaucoma. The interest of this syndrome for pediatric neurosurgeons is mainly related to the association of SWS with epilepsy in 75-90% of the cases. Seizures are resistant to medical treatment in almost 60% of these patients that consequently should be evaluated for epilepsy surgery. INDICATIONS TO SURGICAL TREATMENT: Children with SWS and drug-resistant epilepsy are optimal candidates for disconnective or resective surgical procedures in terms of both seizure control and intellectual outcomes. Controversies, however, still exist between the advantages of early "prophylactic" operation vs later surgical interventions. Though better results in terms of seizures control and psychomotor development were reported in a limited series of children operated on early in life, the insufficient number of subjects who underwent the surgical treatment does not allow definite conclusions yet. NEUROSURGICAL TECHNIQUES: Visually guided lobectomy with complete excision of the angiomatous cortex should be considered as the primary surgical procedure in patients with focal lesions. Hemispherectomy is the treatment of choice in children with extensive hemispheric lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16823586     DOI: 10.1007/s00381-006-0143-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  48 in total

Review 1.  Sturge-Weber syndrome without facial nevus: a case report and review of the literature.

Authors:  A K Gururaj; L Sztriha; J Johansen; M Nork
Journal:  Acta Paediatr       Date:  2000-06       Impact factor: 2.299

2.  Treatment of encephalotrigeminal angiomatosis (Sturge-Weber disease) by hemispherectomy.

Authors:  M A FALCONER; R G RUSHWORTH
Journal:  Arch Dis Child       Date:  1960-10       Impact factor: 3.791

3.  Congenital neurocutaneous syndromes of childhood. III. Sturge-Weber disease.

Authors:  D H CHAO
Journal:  J Pediatr       Date:  1959-11       Impact factor: 4.406

Review 4.  Sturge-Weber syndrome: a review.

Authors:  Kristin A Thomas-Sohl; Dale F Vaslow; Bernard L Maria
Journal:  Pediatr Neurol       Date:  2004-05       Impact factor: 3.372

5.  Innervation pattern of malformative cortical vessels in Sturge-Weber disease: an histochemical, immunohistochemical, and ultrastructural study.

Authors:  M Cunha e Sá; C P Barroso; M C Caldas; L Edvinsson; S Gulbenkian
Journal:  Neurosurgery       Date:  1997-10       Impact factor: 4.654

6.  Prophylactic antiepileptic treatment in Sturge-Weber disease.

Authors:  D Ville; O Enjolras; C Chiron; O Dulac
Journal:  Seizure       Date:  2002-04       Impact factor: 3.184

7.  Psychological functioning in children and adolescents with Sturge-Weber syndrome.

Authors:  L Chapieski; A Friedman; D Lachar
Journal:  J Child Neurol       Date:  2000-10       Impact factor: 1.987

8.  Hemispherectomy for Sturge-Weber syndrome.

Authors:  H J Hoffman; E B Hendrick; M Dennis; D Armstrong
Journal:  Childs Brain       Date:  1979

9.  Epilepsy surgery in bilateral Sturge-Weber syndrome.

Authors:  Ingrid E B Tuxhorn; Heinz W Pannek
Journal:  Pediatr Neurol       Date:  2002-05       Impact factor: 3.372

10.  Encephalotrigeminal angiomatosis.

Authors:  L Feller; J Lemmer
Journal:  SADJ       Date:  2003-10
View more
  20 in total

Review 1.  Differential diagnosis of cerebral hemispheric pathology: multimodal approach.

Authors:  T Moritani; W R K Smoker; H K Lee; Y Sato
Journal:  Clin Neuroradiol       Date:  2011-04-29       Impact factor: 3.649

Review 2.  Multifocal arteriovenous malformations and facial nevus without leptomeningeal angioma: a variant form of Sturge-Weber syndrome? A case report and review of the literatures.

Authors:  In-Seok Bae; Hyeong-Joong Yi; Young Jun Lee
Journal:  Childs Nerv Syst       Date:  2012-09-30       Impact factor: 1.475

3.  Klippel-Trenaunay and Sturge-Weber overlapping syndrome in a Saudi boy.

Authors:  Amal Y Kentab
Journal:  Sudan J Paediatr       Date:  2016

Review 4.  Neurocutaneous vascular syndromes.

Authors:  Katherine B Puttgen; Doris D M Lin
Journal:  Childs Nerv Syst       Date:  2010-06-27       Impact factor: 1.475

5.  Detection of RASA1 mutations in patients with sporadic Sturge-Weber syndrome.

Authors:  Qin Zhou; Jia-wei Zheng; Xiu-juan Yang; Hui-jun Wang; Duan Ma; Zhong-ping Qin
Journal:  Childs Nerv Syst       Date:  2010-09-07       Impact factor: 1.475

6.  Dominant inheritance and intra-familial variations in the association of Sturge-Weber and Klippel-Trenaunay-Weber syndromes.

Authors:  José Maria Pereira de Godoy; Agnes Cristina Fett-Conte
Journal:  Indian J Hum Genet       Date:  2010-01

7.  Seizures continue even after prompt anti-epileptic drug medication in Sturge-Weber syndrome--study from prolonged video electrocoticography, a case report.

Authors:  Hidenori Sugano; Hajime Nakanishi; Madoka Nakajima; Kyoko Tanaka; Kazuaki Shimoji; Konstadin Karagiozov; Hajime Arai
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

8.  Sturge-Weber syndrome-associated glaucoma and intraocular osseous metaplasia: a unique complicated case.

Authors:  Dmytro Pavlenko; Tetiana Scovpen; Oksana Vitovska
Journal:  BMJ Case Rep       Date:  2018-05-16

9.  Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome.

Authors:  Lindsay F Smegal; Alison J Sebold; Adrienne M Hammill; Csaba Juhász; Warren D Lo; Daniel K Miles; Angus A Wilfong; Alex V Levin; Brian Fisher; Karen L Ball; Anna L Pinto; Anne M Comi
Journal:  Pediatr Neurol       Date:  2021-03-05       Impact factor: 4.210

10.  Incidence of Sturge-Weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States.

Authors:  Heba T Rihani; Lauren A Dalvin; David O Hodge; Jose S Pulido
Journal:  Ophthalmic Genet       Date:  2020-03-31       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.